Miscellaneous health services

Tender description

The Healthcare Quality Improvement Partnership (HQIP), commissioning on behalf of NHS England and the health departments of the UK Devolved Nations who wish to participate, invites expressions of interest from suitable providers who are able to provide a national clinical audit of National Paediatric Diabetes Audit as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). To achieve, this national clinical audits must effectively deliver both quality assurance and quality improvement functions at local and national levels. Building on the achievements of the current audit, HQIP will now be recommissioning the NPDA to continue to support quality improvement and quality assurance in paediatric diabetes care. The national diabetes audit (NDA) was established in 2004 as a combined adult and paediatric audit. It was developed as part of the Diabetes National Service Framework (NSF) implementation plan to drive service improvement and monitor the impact of the NSF. In 2011 the adult and paediatric components were tendered separately and the NPDA was thus established to measure outcomes and NICE recommended care processes received by children in Paediatric Diabetes Units (PDUs) in England and Wales. It has, since 2011, been delivered by the Royal College of Paediatric and Child Health and has achieved 100% participation from all 177 units in England and Wales. This contract is being tendered under the Public Contracts Regulation 2015 under an open procurement procedure and has been advertised in accordance with EU requirements. Aims of this National Clinical Audit are: The overarching aim of the NPDA is the collection, analysis and effective reporting of robust comparative data on the quality of care and patient outcomes for young people being cared for in specialist paediatric diabetes units in England and Wales. The audit should at its core be a mechanism to drive improvement within the NHS for the benefit of patients and those working to deliver care. Engagement with clinicians, patients and commissioners (both local and national) and regional networks is therefore essential in order to support improvements. This audit programme is expected to: a. Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement; b. Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate; c. Enable Improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, commissioner, MDT,possibly consultant or clinical team level and other levels of reporting; d. Engage patients, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit; e. Consider the value and feasibility of linking data at an individual patient level to other relevant national data sets either from the outset or in the future, and plan for these linkages from the inception of the contract; f. Ensure robust methodological and statistical input at all stages of the audit; g. Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly; h. Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data; i. Utilise strong and effective project and programme management to deliver audit outputs on time and within budget; j. Close engagement with the adult NDA and to seek opportunities to align scope, methodology and outputs to optimise a whole pathway analysis of diabetes care and outcomes from pregnancy and childhood through to adulthood; and k. Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups in order to drive improvements in services for patients.